Key result
Cardiorenal syndrome in patients hospitalized for heart failure was associated with a significantly higher mortality rate compared to those without the syndrome (25% vs. 13%; P=0.031).
Why the study?
Cardiorenal syndrome involves dysfunction across both heart and kidneys, prompting an evaluation of short-term outcomes and predictors in patients admitted with heart failure complicated by renal impairment.
Does cardiorenal syndrome increase mortality and hospital stay in patients hospitalized for heart failure?
Cross-Sectional (n=170)
No
Does cardiorenal syndrome increase mortality and hospital stay in patients hospitalized for heart failure?
Absolute Event Rate: 25% vs 13%
p-value: p=0.031
Cardiorenal syndrome in patients hospitalized for heart failure is associated with significantly higher short-term mortality, predicted by elevated serum creatinine and urea.
May warrant heightened vigilance in hospitalized HF but should not yet change practice; leaves open whether the association is causal.
Context: Cardiorenal syndrome (CRS) encompasses a spectrum of disorders involving both the heart and kidneys in which acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in the other organ. Aim: To review the short-term outcomes and their predictors among patients admitted with HF complicated by renal impairment. Settings and Design: This was a cross-sectional study conducted at the Aminu Kano Teaching Hospital, Kano, Nigeria. Materials and Methods: Patients aged 18 years and above were consecutively recruited over a period of 11 months. Detailed history and physical examination as well as relevant baseline blood chemistry, full blood count, urinalysis, estimated glomerular filtration rate, ECG, echocardiography, and renal ultrasound were carried out on all patients. Statistical analysis used: The data was analyzed using SPSS Version 16.0. Student t-test and the nonparametric χ2 or Fisher's exact test were used to test for significance among the noncategorical and categorical variables, respectively. Results: One hundred and twenty four (72.9%) patients had CRS. Patients with CRS had a significantly higher mortality rate compared with those without the syndrome (25% vs. 13%; P = 0.031). There was no significant difference in the duration of hospital stay between patients with CRS and those without CRS (17.86 ± 13.11 vs. 15.85 ± 13.46; P = 0.378). Serum creatinine of ≥170 μmol/L and serum urea of >20 mmol/L were the identified predictors of mortality (95% confidence interval [CI] 1.098–6.243, RR = 2.618, P = 0.030; and 95% CI 1.106–6.757, RR = 2.734, P = 0.029, respectively). Conclusion: CRS is associated with a significantly higher mortality rate. Measures of the renal function, serum creatinine >170 μmol/L and serum urea of >20 mmol/L were identified as the predictors of mortality.
No takes yet. Share an insight, caveat, or question.
Shehu et al. (2021) conducted a cross-sectional in Heart failure (n=170). Cardiorenal syndrome vs. No cardiorenal syndrome was evaluated on Mortality (p=0.031). Cardiorenal syndrome in patients hospitalized for heart failure was associated with a significantly higher mortality rate compared to those without the syndrome (25% vs. 13%; P=0.031).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: